Royalty Pharma to Present at Upcoming Investor Conferences
NEW YORK, NY, November 27, 2024 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December.
Events
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
NEW YORK, NY, August 28, 2024 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Morgan Stanley’s 22nd Annual Health Care Conference on September 5, 2024 at 9:15 a.m. ET.
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
NEW YORK, NY, June 4, 2024 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024 at 2:00 p.m. ET.
Royalty Pharma to Present at Upcoming Investor Conferences
NEW YORK, NY, May 13, 2024 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in upcoming investor conferences during the month of May.
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
NEW YORK, NY, February 28, 2024 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. ET.
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK, NY, January 8, 2024 - Royalty Pharma plc (Nasdaq: RPRX) today provided an update on its business performance, including recent key accomplishments, and the full year 2023 outlook for Portfolio Receipts.
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
NEW YORK, NY, November 27, 2023 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 6th Annual HealthCONx Conference on November 28, 2023 at 3:00 p.m. ET.
Royalty Pharma To Present at Upcoming Investor Conferences
NEW YORK, NY, September 5, 2023 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September: Citi’s 18 th Annual BioPharma Conference on Wednesday, September 6 at 11:20 a.m.
Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
NEW YORK, NY, June 7, 2023 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 44 th Annual Global Healthcare Conference on June 13, 2023 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast will be accessible from Royalty Pharma’s “Events” page at
Royalty Pharma To Present At The BofA Securities 2023 Health Care Conference
NEW YORK, NY, May 03, 2023 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 5:20 p.m. ET / 2:20 p.m. PT .
